These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24332604)

  • 1. International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia.
    Barter P
    Clin Investig Arterioscler; 2014; 26(1):21-2. PubMed ID: 24332604
    [No Abstract]   [Full Text] [Related]  

  • 2. [International Atherosclerosis Society guidelines for management of dyslipidemia].
    Millán Núñez-Cortés J
    Clin Investig Arterioscler; 2014; 26(1):20. PubMed ID: 24139446
    [No Abstract]   [Full Text] [Related]  

  • 3. An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia: executive summary.
    Expert Panel on Dyslipidemia
    Atherosclerosis; 2014 Feb; 232(2):410-3. PubMed ID: 24468156
    [No Abstract]   [Full Text] [Related]  

  • 4. [The new 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk: comparison with the ESC/EAS recommendations for the management of dyslipidemias].
    Catapano AL; Averna M; Faggiano P; Novo S
    G Ital Cardiol (Rome); 2014 Jan; 15(1):19-20. PubMed ID: 24503730
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention and treatment of atherosclerosis and cardiovascular diseases].
    Knobler H; Bitzur R; Gavish D; Rubinstein A; Henkin Y; Chajek-Shaul T; Harats D
    Harefuah; 2012 May; 151(5):281-8, 319, 318. PubMed ID: 22844732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia.
    ; Grundy SM
    J Clin Lipidol; 2013; 7(6):561-5. PubMed ID: 24314355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Decalogue of clinical recommendations on atherogenic dyslipidemia].
    Pedro-Botet J; Millán J; Brea Á; Díaz Á; González-Santos P; Hernández-Mijares A; Mantilla T; Pintó X; Simó R
    Clin Investig Arterioscler; 2014; 26(1):38-40. PubMed ID: 24365580
    [No Abstract]   [Full Text] [Related]  

  • 8. [Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidelines related to the diagnostics and treatment of dyslipidemias issued in 2011].
    Soška V; Vaverková H; Vráblík M; Bláha V; Cífková R; Freiberger T; Kraml P; Piťha J; Rosolová H; Stulc T; Urbanová Z
    Vnitr Lek; 2013 Feb; 59(2):120-6. PubMed ID: 23461401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary].
    ; Grundy SM; Arai H; Barter P; Bersot TP; Betteridge DJ; Carmena R; Cuevas A; Davidson MH; Genest J; Kesäniemi YA; Sadikot S; Santos RD; Susekov A; Sy R; Tokgozoglu L; Watts GF; Zhao D;
    Clin Investig Arterioscler; 2014; 26(1):33-7. PubMed ID: 24169377
    [No Abstract]   [Full Text] [Related]  

  • 10. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia--full report.
    Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members
    J Clin Lipidol; 2014; 8(1):29-60. PubMed ID: 24528685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on "pediatric dyslipidemia: recommendations for clinical management".
    Balaguru D
    South Med J; 2015 Jan; 108(1):15-6. PubMed ID: 25580751
    [No Abstract]   [Full Text] [Related]  

  • 12. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
    ; Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Perrone Filardi P; Riccardi G; Storey RF; Wood D;
    Atherosclerosis; 2011 Jul; 217 Suppl 1():S1-44. PubMed ID: 21723445
    [No Abstract]   [Full Text] [Related]  

  • 13. Atherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment: Expert's position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS).
    Ponte-Negretti CI; Isea-Perez JE; Lorenzatti AJ; Lopez-Jaramillo P; Wyss-Q FS; Pintó X; Lanas F; Medina J; Machado-H LT; Acevedo M; Varleta P; Bryce A; Carrera C; Peñaherrera CE; Gómez-M JR; Lozada A; Merchan-V A; Piskorz D; Morales E; Paniagua M; Medina-Palomin F; Villar-M RA; Cobos L; Gómez-Alvares E; Alonso R; Colan J; Chirinos J; Lara J; Ullauri V; Arocha I
    Int J Cardiol; 2017 Sep; 243():516-522. PubMed ID: 28552520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.
    MacNair K; Bugden S;
    Can J Cardiol; 2007 May; 23(6):481-2; author reply 483. PubMed ID: 17549843
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment to the position paper on global recommendations for the management of dyslipidemia developed by the International Atherosclerosis Society (IAS).
    Catapano AL; Chapman MJ; de Backer G; Taskinen MR; Reiner Ž; Wiklund O
    Atherosclerosis; 2014 Apr; 233(2):508-509. PubMed ID: 24530786
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of inherited atherogenic dyslipidemias in children.
    Guardamagna O; Cagliero P; Abello F
    Ther Apher Dial; 2013 Apr; 17(2):150-61. PubMed ID: 23551671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to apply clinical guidelines in medical practice? The example of dyslipidemia].
    Pasche O; Pache S; Cornuz J; Darioli R; Rodondi N
    Rev Med Suisse; 2008 Mar; 4(148):662-5. PubMed ID: 18459662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A commentary on some inconsistencies in the icrp 2005 recommendations: exclusion levels.
    Kramer GH
    Health Phys; 2006 Jul; 91(1):1-6. PubMed ID: 16775474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New european guidelines for dyslipidemia].
    Riesen WF; Virgini V; Vogt B; Rodondi N
    Rev Med Suisse; 2012 Mar; 8(331):525-6, 528-30. PubMed ID: 22471115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel.
    Anderson TJ; Grégoire J; Hegele RA; Couture P; Mancini GB; McPherson R; Francis GA; Poirier P; Lau DC; Grover S; Genest J; Carpentier AC; Dufour R; Gupta M; Ward R; Leiter LA; Lonn E; Ng DS; Pearson GJ; Yates GM; Stone JA; Ur E
    Can J Cardiol; 2014 Apr; 30(4):377-80. PubMed ID: 24589194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.